Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform

INTRODUCTION: COVID-19 is a new viral-induced pneumonia caused by infection with a novel coronavirus, SARS-CoV-2. At present, there are few proven effective treatments. This early-phase experimental medicine protocol describes an overarching and adaptive trial designed to provide safety data in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaughan, Erin, Quinn, Tom, Bruce, Annya, Antonelli, Jean, Young, Vikki, Mair, Joanne, Akram, Ahsan, Hirani, Nik, Koch, Oliver, Mackintosh, Claire, Norrie, John, Dear, James W, Dhaliwal, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678561/
https://www.ncbi.nlm.nih.gov/pubmed/34911721
http://dx.doi.org/10.1136/bmjopen-2021-054442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678561/
https://www.ncbi.nlm.nih.gov/pubmed/34911721
http://dx.doi.org/10.1136/bmjopen-2021-054442

Ejemplares similares